Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital. Diagnosis and Clinical Management of 2019 Novel Coronavirus(2019-nCoV) Infection: An Operational Recommendation of Peking Union Medical College Hospital(V2.0)[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 672-675. DOI: 10.3969/j.issn.1674-9081.20200022
Citation: Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital. Diagnosis and Clinical Management of 2019 Novel Coronavirus(2019-nCoV) Infection: An Operational Recommendation of Peking Union Medical College Hospital(V2.0)[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 672-675. DOI: 10.3969/j.issn.1674-9081.20200022

Diagnosis and Clinical Management of 2019 Novel Coronavirus(2019-nCoV) Infection: An Operational Recommendation of Peking Union Medical College Hospital(V2.0)

More Information
  • Corresponding author:

    LI Tai-sheng  E-mail: litsh@263.net

  • Received Date: January 26, 2020
  • Accepted Date: January 26, 2020
  • Available Online: January 29, 2020
  • Issue Publish Date: November 29, 2020
  • Since December 2019, China has been experiencing an outbreak of a new infectious disease caused by 2019 novel coronavirus (2019-nCoV). The clinical features include fever, coughing, shortness of breath, and inflammatory lung infiltration. China rapidly listed 2019-nCoV-related pneumonia as a statutory infectious disease. To standardize the diagnosis and treatment of this new infectious disease, an operational recommendation for the diagnosis and management of 2019-nCoV infection is developed by Peking Union Medical College Hospital.
  • [1]
    国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎诊疗方案(试行第三版)[EB/OL]. (2020-01-23).http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2f-fcbee1fa/files/39e7578d85964dbe81117736dd789d8f.pdf.
    [2]
    World Health Organization.Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection issuspected[EB/OL].https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
    [3]
    Li TS, Qiu ZF, Han Y, et al. Rapid loss of both CD4 and CD8 T lymphocyte subsets during the acute phase of severe acute respiratory syndrome[J]. Chin Med J, 2003, 116:985-987.
    [4]
    李太生, 邱志峰, 韩扬, 等.严重急性呼吸综合症急性期T淋巴细胞亚群异常改变[J].中华检验医学杂志, 2003, 26:297-299.
    [5]
    耿陶然, 韩扬, 李太生, 等.重症流感患者T淋巴细胞与预后研究[J].中华内科杂志, 2020, 59:200-206.
    [6]
    Mori I, Parizot C, Dorgham K, et al. Prominent plasma-cytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome[J]. PLoS One, 2008, 3:e2109.
    [7]
    Hemming VG. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases[J].Clin Diagn Lab Immunol, 2001, 8:859-863.

Catalog

    Article Metrics

    Article views (474) PDF downloads (181) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close